Dear Contractor,

You will be aware of the announcement on Monday 31 March 2025 that community pharmacy contractual and funding arrangements have been agreed for 2024/25 and 2025/26 in England.

Further information on the English 2024/25 and 2025/26 contractual and funding arrangements is available here7(70%). The agreement reached is the result of negotiations between NHS (England), DHSC, and Community Pharmacy England (CPE) that began last year and concluded recently.

The economic report produced by IQVIA and Frontier Economics, that was used to provide the economic evidence in those negotiations is available 

Whilst the agreement relates to English community pharmacy contractual and funding arrangements, CPNI has nonetheless written to the Health Minister, Mr Mike Nesbitt MLA reiterating the need for negotiations to take place between DoH(NI), SPPG and CPNI so that contractual and funding arrangements for community pharmacy services in Northern Ireland can be negotiated and agreed. The need to mitigate the impact of the imminent increases to Employer NIC and NMW/NLW costs in 2025/26 was also raised in the letter.

Please do not hesitate to contact CPNI offices should you require any additional information or clarification on the English announcement or in relation to community pharmacy funding matters in Northern Ireland.

Kind regards,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
DHNI has written to contractors (here) enclosing a link to the online controlled drug declaration and self-assessment for 2025 which is mandated under The Controlled Drugs (Supervision of Management and Use) Regulations (Northern Ireland) 2009.

Action

Contractors are reminded that this online questionnaire must be completed by 11 April 2025.

If you have any queries regarding the completion of the questionnaire, in the first instance please contact Michelle Keatings (02890 520230) michelle.keatings@health-ni.gov.uk or Claire O’Reilly (02890 520219) claire.oreilly@health-ni.gov.uk.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Colleague
The following concessionary prices granted in March 2025 have rolled over to April 2025:
DrugPack SizeConcessionary Price
Fusidic acid 1% modified-release eye drops5£21.00
Oxybutynin 2.5mg tablets56£1.11
Timolol 0.5% eye drops5£1.63
Venlafaxine 300mg modified-release tablets30£43.09

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for March 2025:
DrugPack SizeConcessionary Price
Ascorbic acid 500mg tablets28£36.08
Captopril 50mg tablets56£23.50
Clarithromycin 250mg/5ml oral suspension70£8.41
Desmopressin 120microgram sublingual tablets sugar free30£18.09
Desogestrel 75microgram tablets84£2.37
Duloxetine 30mg gastro-resistant capsules28£1.84
Duloxetine 60mg gastro-resistant capsules28£1.93
Fusidic acid 1% modified-release eye drops5£21.00
Ivermectin 10mg/g cream45£36.58
Latanoprost 50micrograms/ml eye drops2.5£1.59
Lercanidipine 10mg tablets28£3.64
Letrozole 2.5mg tablets28£1.82
Lofepramine 70mg tablets56£24.33
Lorazepam 1mg tablets28£2.53
Melatonin 2mg modified-release tablets30£2.72
Metformin 1g / Sitagliptin 50mg tablets56£7.55
Metronidazole 400mg tablets21£1.86
Midazolam 10mg/2ml solution for injection ampoules10£5.11
Mometasone 0.1% cream30£3.59
Morphine sulfate 10mg/1ml solution
for injection ampoules
10£4.78
Oxybutynin 2.5mg tablets56£1.11
Paracetamol 250mg/5ml oral suspension sugar free200£5.53
Paracetamol 500mg effervescent tablets100£5.37
Pregabalin 20mg/ml oral solution sugar free473£51.36
Prochlorperazine 3mg buccal tablets50£20.33
Prucalopride 1mg tablets28£20.15
Prucalopride 2mg tablets28£9.87
Riluzole 50mg tablets56£311.11
Tadalafil 2.5mg tablets28£10.85
Tadalafil 5mg tablets28£4.60
Telmisartan 80mg tablets28£7.04
Timolol 0.5% eye drops5£1.63
Trihexyphenidyl 2mg tablets84£3.10
Trimethoprim 200mg tablets6£0.88
Trimethoprim 200mg tablets14£2.05
Trimethoprim 50mg/5ml oral suspension sugar free100£4.88
Vardenafil 20mg tablets4£17.82
Venlafaxine 225mg modified-release capsules28£20.71
Venlafaxine 300mg modified-release tablets30£43.09

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
*** Webinar tomorrow 1 April 6.30-7.30pm ***
Dear Contractor
CPNI issued contractor emails on 10 March 2025 and 24 March 2025 regarding a pilot to support community pharmacist access to Independent Prescriber (IP) training by providing funding for those who agree to act as a DPP.  Information on the pilot is available here and on the NICPLD IP webpage.

A final information webinar will be held tomorrow (1 April 2025) 6.30-7.30pm.

SUMMARY

  • Community pharmacists who wish to apply for the NICPLD Independent Prescribing (IP) course can submit applications up to 15 April 2025.
  • To undertake IP training, community pharmacists must have a Designated Prescribing Practitioner (DPP).
  • In recognition of the difficulties faced by community pharmacists in securing a DPP, a pilot has now been launched in which funding of £1500 is available for up to 50 eligible DPPs who agree to support a community pharmacist.
  • NICPLD has indicated that a number of DPPs have come forward to indicate that they are willing to support a community pharmacist trainee.  
  • The pilot funding will only be available for those commencing training in August 2025.
  • A final information webinar for prospective applicants or DPPs will be held tomorrow 1 April 2025 6.30-7.30pm with registration available here or by emailing nicpld-prescribing@qub.ac.uk.

ACTION

  • Contractors are asked to note the information provided above and share with relevant members of the team, including any community pharmacists considering IP training, and any existing community pharmacist IPs who may consider acting as a DPP under the support scheme.

Queries on the DPP support scheme can be sent to nicpld-prescribing@qub.ac.uk. Alternatively, please do not hesitate to contact the CPNI team or email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
**FOR THE ATTENTION OF LIVING WELL PHARMACIES ONLY**
Dear Contractor
Correspondence has been issued by SPPG on 31 March 2025 regarding the launch of the Living Well survey for the campaign ‘Look after your mental health’.

SUMMARY

  • The survey for the campaign ‘Look after your mental health’ is open and can be accessed here.
  • The survey must be completed by 6pm on 28 April 2025, please ensure to reach the final screen to confirm submission.

ACTION

Contractors are asked to review the SPPG correspondence issued on 31 March 2025 and share with all relevant members of the pharmacy team.

For any further information please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive